amrinone has been researched along with MODS in 1 studies
Amrinone: A positive inotropic cardiotonic (CARDIOTONIC AGENTS) with vasodilator properties, phosphodiesterase 3 inhibitory activity, and the ability to stimulate calcium ion influx into the cardiac cell.
amrinone : A 3,4'-bipyridine substituted at positions 5 and 6 by an amino group and a keto function respectively. A pyridine phosphodiesterase 3 inhibitor, it is a drug that may improve the prognosis in patients with congestive heart failure.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This case report details the pharmacokinetic adjustments of an amrinone infusion in a paediatric patient who developed multiorgan system failure with anuric renal failure and was prescribed continuous arteriovenous haemofiltration." | 1.29 | Effect of continuous arteriovenous haemofiltration on pharmacokinetics of amrinone. ( Azin, S; Corddry, D; Lawless, S; Restaino, I, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lawless, S | 1 |
| Restaino, I | 1 |
| Azin, S | 1 |
| Corddry, D | 1 |
1 other study available for amrinone and MODS
| Article | Year |
|---|---|
Effect of continuous arteriovenous haemofiltration on pharmacokinetics of amrinone.
Topics: Acute Kidney Injury; Amrinone; Child; Female; Half-Life; Hemofiltration; Humans; Metabolic Clearance | 1993 |